These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
923 related articles for article (PubMed ID: 32773013)
41. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677 [TBL] [Abstract][Full Text] [Related]
42. Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial. Johnston TJ; Shaw GL; Lamb AD; Parashar D; Greenberg D; Xiong T; Edwards AL; Gnanapragasam V; Holding P; Herbert P; Davis M; Mizielinsk E; Lane JA; Oxley J; Robinson M; Mason M; Staffurth J; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Prescott S; Paul A; Powell P; Rosario D; Rowe E; Donovan JL; Hamdy FC; Neal DE; Eur Urol; 2017 Mar; 71(3):381-388. PubMed ID: 27720537 [TBL] [Abstract][Full Text] [Related]
43. Primary cryotherapy for localised or locally advanced prostate cancer. Jung JH; Risk MC; Goldfarb R; Reddy B; Coles B; Dahm P Cochrane Database Syst Rev; 2018 May; 5(5):CD005010. PubMed ID: 29845595 [TBL] [Abstract][Full Text] [Related]
44. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT. Heer R; Lewis R; Duncan A; Penegar S; Vadiveloo T; Clark E; Yu G; Mariappan P; Cresswell J; McGrath J; N'Dow J; Nabi G; Mostafid H; Kelly J; Ramsay C; Lazarowicz H; Allan A; Breckons M; Campbell K; Campbell L; Feber A; McDonald A; Norrie J; Orozco-Leal G; Rice S; Tandogdu Z; Taylor E; Wilson L; Vale L; MacLennan G; Hall E Health Technol Assess; 2022 Oct; 26(40):1-144. PubMed ID: 36300825 [TBL] [Abstract][Full Text] [Related]
45. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579 [TBL] [Abstract][Full Text] [Related]
46. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
47. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475 [TBL] [Abstract][Full Text] [Related]
48. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT. Adamson D; Blazeby J; Porter C; Hurt C; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Byrne A Health Technol Assess; 2021 May; 25(31):1-144. PubMed ID: 34042566 [TBL] [Abstract][Full Text] [Related]
49. Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation. Souto-Ribeiro I; Woods L; Maund E; Alexander Scott D; Lord J; Picot J; Shepherd J Health Technol Assess; 2024 Oct; 28(60):1-213. PubMed ID: 39364806 [TBL] [Abstract][Full Text] [Related]
50. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
51. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial. Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529 [TBL] [Abstract][Full Text] [Related]
52. Screening for prostate cancer. Ilic D; Neuberger MM; Djulbegovic M; Dahm P Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794 [TBL] [Abstract][Full Text] [Related]
53. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135 [TBL] [Abstract][Full Text] [Related]
54. An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia: the Journeying through Dementia RCT. Mountain G; Wright J; Cooper CL; Lee E; Sprange K; Beresford-Dent J; Young T; Walters S; Berry K; Dening T; Loban A; Turton E; Thomas BD; Young EL; Thompson BJ; Crawford B; Craig C; Bowie P; Moniz-Cook E; Foster A Health Technol Assess; 2022 May; 26(24):1-152. PubMed ID: 35536231 [TBL] [Abstract][Full Text] [Related]
55. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer. Wilt TJ J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771 [TBL] [Abstract][Full Text] [Related]
56. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Vale CL; Fisher D; Kneebone A; Parker C; Pearse M; Richaud P; Sargos P; Sydes MR; Brawley C; Brihoum M; Brown C; Chabaud S; Cook A; Forcat S; Fraser-Browne C; Latorzeff I; Parmar MKB; Tierney JF; Lancet; 2020 Oct; 396(10260):1422-1431. PubMed ID: 33002431 [TBL] [Abstract][Full Text] [Related]
57. Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT. Rodgers H; Bosomworth H; Krebs HI; van Wijck F; Howel D; Wilson N; Finch T; Alvarado N; Ternent L; Fernandez-Garcia C; Aird L; Andole S; Cohen DL; Dawson J; Ford GA; Francis R; Hogg S; Hughes N; Price CI; Turner DL; Vale L; Wilkes S; Shaw L Health Technol Assess; 2020 Oct; 24(54):1-232. PubMed ID: 33140719 [TBL] [Abstract][Full Text] [Related]
58. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT. Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845 [TBL] [Abstract][Full Text] [Related]